Adocia SA (ADOC.PA) Stock Price
€5.38 0.4%
to add to portfolio
AI Score

-
Alternative
3 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Adocia SA, AI stock picks, stock alerts and much more.
ADOC.PA AI Stock Analysis
AI stock analysis for ADOC.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Adocia SA (ADOC.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Adocia SA (ADOC.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Adocia SA (ADOC.PA), currently trading at €5.38, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ADOC.PA

-
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.
-
Symbol
ADOC.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
84.4M
Similar Stocks
![]() |
Valneva SE VLA.PA |
€3.78 2.1% |
3 |
![]() |
Financière de Tubize SA TUB.BR |
€154 0.1% |
5 |
![]() |
OSE Immunotherapeutics SA OSE.PA |
€7.07 4.1% |
4 |
![]() |
UCB SA UCB.BR |
€189.8 0.2% |
7 |
![]() |
Innate Pharma S.A. IPH.PA |
€1.9 1.1% |
2 |
ADOC.PA Alternative Data
Web Traffic
Adocia SA receives an estimated 2484 monthly visitors to adocia.com, which is up by 2.3% over the last month.
-
Web Traffic
2484
-
Change from Previous Month
2.3%
-
3 Month Change
30.4%
News Mentions
Adocia SA was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Adocia SA has 276 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.5% over the last month.
-
Twitter Followers
276
-
Daily Change
0%
-
1 Month Change
1.5%
-
3 Month Change
4.5%
Youtube Subscribers
Adocia SA has 81 subscribers on its main Youtube channel, up by 1.3% over the last month.
-
Youtube Subscribers
81
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
5.2%
Job Postings
Adocia SA has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
LinkedIn Employees
According to LinkedIn, Adocia SA has 88 employees, down by -2.2% over the last month.
-
LinkedIn Employees
88
-
Daily Change
0%
-
1 Month Change
2.2%
-
3 Month Change
0%
Business Outlook
-
Business Outlook
17
-
Change from Previous Month
10.5%
-
3 Month Change
0%
-
YoY Change
0%
ADOC.PA Financials
ADOC.PA Key Metrics
-
Total Revenue
€0
-
Net Income
-€8.9M
-
Earnings per Share
-€0.62
-
Free cash flow
-€10.5M
-
EBITDA
-€9.4M
-
EBITDA Ratio
0
-
Total Assets
€23.7M
ADOC.PA 2-year Revenue & Income
ADOC.PA 2-year Free Cash Flow
ADOC.PA Technicals
ADOC.PA SMA
ADOC.PA RSI
FAQ
What's the current price of Adocia SA (ADOC.PA) Stock?
The price of an Adocia SA (ADOC.PA) share is €5.38.
What's the market cap of Adocia SA?
The current market cap of Adocia SA is 84.4M.
Should I buy or sell ADOC.PA?
Adocia SA exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Adocia SA a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Adocia SA stock. There are several bearish signals and market challenges that could negatively impact Adocia SA's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Adocia SA (ADOC.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Adocia SA stock right now, as the outlook appears bearish.
What are some stocks similar to Adocia SA (ADOC.PA) that investors often compare it to?
Adocia SA (ADOC.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Adocia SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Adocia SA's stock price to be around €4.89 in 2026. Starting from the current price of €5.38, this represents a 9% change in price, indicating a bearish outlook for the stock.
How to buy Adocia SA (ADOC.PA) Stock?
Adocia SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Adocia SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.